New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

Monkeys infected with the deadly Ebola virus have been successfully cured by a 10-day regimen of pills, leading scientists to hope the treatment could be adapted for use in humans. The drug, ...

Scientists have found that an oral antiviral drug successfully prevents monkeys from dying after an Ebola infection, an ...

Monkeys infected with Ebola can be cured with a pill, according to a new study that could pave the way for more practical, ...

The pill protected 80 per cent of the cynomolgus macaques and 100 per cent of the rhesus macaques, which are biologically ...

SCIENTISTS have found a pill that offers ‘100 per cent protection’ against Ebola – sparking hopes of eradicating the deadly ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

Get Instant Summarized Text (Gist) Research on the human antibody mAb 3A6 highlights its potential in Ebola virus therapeutics. Isolated from an Ebola survivor, mAb 3A6 binds to the virus's "stalk ...

Uganda's Ebola virus caseload has risen to 12, up from 10, with two people who died early last month being considered ...

In 2023, he received the prestigious Sabin Vaccine Institute Gold Medal for developing other innovative vaccines for Ebola Zaire, smallpox, Japanese encephalitis, and West Nile virus, among others.

Lassa fever does not spread easily between people and the overall risk to the public is regarded as ‘very low’ ...